Swiss National Bank Atai Life Sciences N.V. Transaction History

Swiss National Bank

  • $143 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$1.17 - $2.7 $28,548 - $65,880
-24,400 Reduced 8.33%
268,600 $486,000
Q4 2022

Feb 08, 2023
BUY
$2.38 - $3.55 $21,658 - $32,305
9,100 Added 3.21%
293,000 $779,000
Q2 2022

Aug 09, 2022
BUY
$3.03 - $5.32 $860,217 - $1.51 Million
283,900 New
283,900 $1.03 Million

Others Institutions Holding ATAI

# of Institutions
99
Shares Held
12.7M
Call Options Held
9.2K
Put Options Held
118K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $206M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email